FDA’s Focus on Review Efficiency, Scientific Evidence, Product Modifications, and Market Authorization The first day of the 2026 FDLI Tobacco and Nicotine Products Regulation and Policy Conference provided valuable insight into the evolving...
Achievement recognizes Labstat’s 50-year commitment to scientific quality, integrity, and global regulatory support. KITCHENER, Ontario – May 21, 2026 – Labstat Inc., a Certified Group company and the world’s largest independent nicotine and tobacco contract research...
UPDATE: Labstat was officially awarded OECD GLP certification on May 13, 2026. View our GLP Certification here. “We’re pleased to share an important milestone in Labstat’s GLP recognition process with the Standards Council of Canada (SCC). Following a recent...
1-Minute Summary Global demand for oral nicotine pouches is growing, and FDA actions (recent authorizations and a PMTA pilot) are shaping a clearer path to market. Nicotine dissolution testing shows how fast and how much nicotine a pouch releases – key for...
TSRC 2025 is behind us (read our TSRC wrap up here), and the industry has turned its attention to CORESTA 2025, which shall be held in Annecy, France. CORESTA 2025 19-23 October | Annecy, France The Labstat team is excited to present new research...
The 78th Tobacco Science Research Conference (TSRC) devoted a full session to risk assessment, and it delivered practical tools, candid debate on 2024 FDA CTP tox memos (“Genotoxicity Hazard Identification and Carcinogenicity Tiering of Constituents in ENDS Premarket...
